Form D · Other
Syzygy Plasmonics Inc.
Houston, TX · CIK 0001785743
Offering snapshot reported Nov 17, 2022 · SEC filing
- Reported sold
- $76.7M Offering amount: $76.7M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2022 | Initial | $76,686,283 | No comparison | 17 | SEC filing |
| Apr 6, 2021 | Initial | $22,784,985 | No comparison | 10 | SEC filing |
| Dec 2, 2019 | Amendment | $10,702,000 | $3,935,000vs Aug 19, 2019 | 31 | SEC filing |
| Aug 19, 2019 | Initial | $6,767,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465153
Source: Form D, filed Nov 17, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Trevor Best | Director, Executive |
| Michael Biddle | Director |
| Mike Biddle | Director |
| Ann De Witt | Director |
| Josh Dienstag | Director |
| Matthew Hill | Director |
| Don Kendall | Director |
| Donald R. Kendall Jr. | Director |
| Suman Khatiwada Khatiwada | Director, Executive |
| Suman Khatiwada | Director, Executive |
| Kerry Liu | Director |
| Patrick Poon | Director |
Issuer details
Industry: Other (See others in industry)
Address:
9000 Kirby Dr.
Houston, TX, 77054
Houston, TX, 77054